These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
547 related articles for article (PubMed ID: 25148289)
21. The state of the art in non-small cell lung cancer immunotherapy. Seetharamu N Semin Thorac Cardiovasc Surg; 2014; 26(1):26-35. PubMed ID: 24952755 [TBL] [Abstract][Full Text] [Related]
22. Belagenpumatucel-L for the treatment of non-small cell lung cancer. Rijavec E; Biello F; Genova C; Barletta G; Maggioni C; Dal Bello MG; Coco S; Truini A; Vanni I; Alama A; Beltramini S; Grassi MA; Boccardo F; Grossi F Expert Opin Biol Ther; 2015; 15(9):1371-9. PubMed ID: 26211534 [TBL] [Abstract][Full Text] [Related]
26. MAGRIT: the largest-ever phase III lung cancer trial aims to establish a novel tumor-specific approach to therapy. Tyagi P; Mirakhur B Clin Lung Cancer; 2009 Sep; 10(5):371-4. PubMed ID: 19808198 [TBL] [Abstract][Full Text] [Related]
27. What lies within: novel strategies in immunotherapy for non-small cell lung cancer. Forde PM; Reiss KA; Zeidan AM; Brahmer JR Oncologist; 2013; 18(11):1203-13. PubMed ID: 24105749 [TBL] [Abstract][Full Text] [Related]
28. Vaccination therapy for non-small-cell lung cancer: review of agents in phase III development. Decoster L; Wauters I; Vansteenkiste JF Ann Oncol; 2012 Jun; 23(6):1387-93. PubMed ID: 22156658 [TBL] [Abstract][Full Text] [Related]
29. Cancer immunotherapy: a future paradigm shift in the treatment of non-small cell lung cancer. Anagnostou VK; Brahmer JR Clin Cancer Res; 2015 Mar; 21(5):976-84. PubMed ID: 25733707 [TBL] [Abstract][Full Text] [Related]
30. Immune alterations and emerging immunotherapeutic approaches in lung cancer. Dasanu CA; Sethi N; Ahmed N Expert Opin Biol Ther; 2012 Jul; 12(7):923-37. PubMed ID: 22559147 [TBL] [Abstract][Full Text] [Related]
31. Cancer vaccines: a new therapeutic alternative for lung cancer therapy? Raez LE; Santos ES Immunotherapy; 2009 Sep; 1(5):727-8. PubMed ID: 20636014 [No Abstract] [Full Text] [Related]
32. Active specific immunotherapy and cell-transfer therapy for the treatment of non-small cell lung cancer. Kakimi K; Nakajima J; Wada H Lung Cancer; 2009 Jul; 65(1):1-8. PubMed ID: 19062127 [TBL] [Abstract][Full Text] [Related]
33. Immunotherapy for lung cancer: for whom the bell tolls? Madureira P; de Mello RA; de Vasconcelos A; Zhang Y Tumour Biol; 2015 Mar; 36(3):1411-22. PubMed ID: 25736929 [TBL] [Abstract][Full Text] [Related]